Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 68,481 |
|
|||||
| News | - | ||||||
| Day High | 11.73 | Low High |
|||||
| Day Low | 10.83 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| INmune Bio Inc | INMB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.43 | 3.97% | 11.27 | 15:51:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.83 | 10.83 | 11.73 | 10.84 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,018 | 68,481 | $ 11.43 | $ 782,717 | - | 6.5001 - 14.74 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:52:17 | 1 | $ 11.285 | USD |
INmune Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 207.61M | 18.02M | - | 155k | -30.01M | -1.67 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
INmune Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INMB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.76 | 11.73 | 8.30 | 10.44 | 233,167 | 2.51 | 28.65% |
| 1 Month | 11.75 | 11.85 | 8.30 | 10.25 | 155,585 | -0.48 | -4.09% |
| 3 Months | 10.43 | 14.74 | 8.30 | 11.31 | 101,192 | 0.84 | 8.05% |
| 6 Months | 7.12 | 14.74 | 6.63 | 11.04 | 82,991 | 4.15 | 58.29% |
| 1 Year | 7.05 | 14.74 | 6.5001 | 10.03 | 66,858 | 4.22 | 59.86% |
| 3 Years | 12.28 | 30.37 | 4.6288 | 14.19 | 141,847 | -1.01 | -8.22% |
| 5 Years | 10.80 | 30.37 | 2.20 | 14.11 | 173,501 | 0.47 | 4.35% |
INmune Bio Description
| INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others. |
